We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Testing Unravels Unusual Patterns for Fragile-X Syndrome

By LabMedica International staff writers
Posted on 11 Dec 2017
Fragile-X syndrome is an X-linked disorder with a prevalence of about 1 in 3,600 to 4,000 in males and 1 in 4,000 to 6,000 in females and is the main cause of inherited intellectual disability (ID) and cognitive impairment.

Fragile-X syndrome (FXS) is a rare disease and ID is frequently associated with chromosomal imbalances that often involve the X chromosome, and most clinicians primarily request molecular diagnosis of FXS for patients affected by any type of ID or developmental delay.

Scientists at the University of Naples Federico II (Naples, Italy) and their colleagues studied three women affected by intellectual/psychomotor delay and primary or secondary amenorrhea, and six men affected by mental retardation or psychomotor delay. More...
The enrollees underwent FXS molecular diagnosis and resulted to have normal CGG triplets in the Fragile X Mental Retardation 1 (FMR1) gene, but showed atypical X chromosome patterns. Further diagnostic investigations and, in two females, array-comparative genomic hybridization (array-CGH) revealed the possible genetic cause of their conditions.

The team extracted DNA from 10 mL of whole blood samples from each subject and the CGG repeat number of FMR1 alleles up to 160 CGG repeats was determined by capillary gel electrophoresis of fluorescent-labeled DNA amplicons using primers F (labeled with NED fluorochrome) and C. The triplet repeat primed polymerase chain reaction (TP-PCR) and the Southern blot analysis of genomic DNA digested with restriction enzymes were performed. The X-inactivation analysis was carried out with the PCR-based method for methylation-dependent amplification of the polymorphic triplet repeats at the human androgen receptor (HUMARA) gene. Amplification products were separated by capillary gel electrophoresis on the ABI Prism 3130 genetic analyzer.

The investigators reported that six men affected by ID and three women affected by ID and fragile X-associated premature ovarian failure/ primary ovarian insufficiency (POF/POI) underwent FXS molecular testing. They had normal FMR1 CGG repeats, but atypical X chromosome patterns. Further investigations revealed that the six males had Klinefelter syndrome (XXY), one female was a Turner mosaic (X0/XX) and two women had novel rearrangements involving X chromosome.

The authors concluded that diagnostic investigation of atypical patterns at FMR1 locus can address patients and/or their relatives to further verify the condition by performing karyotyping and/or array-CGH. They emphasize that, for all the presented patients, their diagnostic report concluded for the absence of pathological expansion in the FMR1 gene and the presence of analytical findings that were suggestive of X chromosome abnormality. The study was published online on November 21, 2017, in the journal Clinica Chimica Acta.

Related Links:
University of Naples Federico II


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automated Urinalysis Solution
UN-9000
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.